Important Drug Safety Update from the MHRA on Valproate and pregnancy

24th April 2018

The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.

Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met

More News

SCRIPT Accepted to RCN Education Forum Conference

SCRIPT is delighted to announce that we will be presenting a poster at the Royal College of Nursing (RCN) Education Forum National Conference and Exhibition 2025. The conference will be held at the Technology and Innovation Centre (TIC) in Glasgow and SCRIPT will be...

New SCRIPT Antidepressant Deprescribing Modules

SCRIPT has launched two new modules titled ‘Antidepressant Deprescribing (Part 1): The Principles’ and ‘Antidepressant Deprescribing (Part 2): The Practicalities’ in the Medicine & Surgery and Primary Care portfolios. These modules are designed to help prescribers...